Cargando…

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.

Differential drug response in a human cell line panel representing defined types of cytotoxic drug resistance was measured using the non-clonogenic fluorometric microculture cytotoxicity assay (FMCA). In total 37 drugs were analysed; eight topoisomerase II inhibitors, eight anti-metabolites, eight a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhar, S., Nygren, P., Csoka, K., Botling, J., Nilsson, K., Larsson, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074735/ https://www.ncbi.nlm.nih.gov/pubmed/8826854

Ejemplares similares

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
por: Rickardson, L, et al.
Publicado: (2005)

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
por: Beesley, A H, et al.
Publicado: (2006)

Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
por: Nygren, P., et al.
Publicado: (1991)

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
por: Andersson, Claes R., et al.
Publicado: (2022)

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
por: Kenicer, Juliet, et al.
Publicado: (2014)

Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy
por: Hultman, Bo, et al.
Publicado: (2014)

Identifying representative drug resistant mutants of HIV
por: Yu, Xiaxia, et al.
Publicado: (2015)

Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma
por: Goel, Utkarsh, et al.
Publicado: (2023)

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
por: Mujuni, Dennis, et al.
Publicado: (2022)

Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosis
por: Umar, Faiqah F., et al.
Publicado: (2020)

Molecular and genomic characterisation of a panel of human anal cancer cell lines
por: Guerra, Glen R., et al.
Publicado: (2021)

GenoType(®) MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2016)

Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
por: Larsson, R., et al.
Publicado: (1998)

Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
por: Fridborg, H., et al.
Publicado: (1994)

Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
por: Michaelis, Martin, et al.
Publicado: (2020)

Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand
por: Lopes, Dinora, et al.
Publicado: (2002)

Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan
por: Napier, Gary, et al.
Publicado: (2022)

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

Epigenetic Effects of Drugs of Abuse
por: Heinbockel, Thomas, et al.
Publicado: (2018)

Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
por: Snow, K., et al.
Publicado: (1991)

Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.
por: Jonsson, E., et al.
Publicado: (1997)

An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
por: Wainberg, Mark A
Publicado: (2011)

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism
por: Kashif, Muhammad, et al.
Publicado: (2017)

Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
por: Heavey, Susan, et al.
Publicado: (2018)

Characterisation of new anti-O157 bacteriophages of bovine origin representing three genera
por: Sváb, Domonkos, et al.
Publicado: (2022)

Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela
por: Aristimuño, Liselotte, et al.
Publicado: (2006)

Characterisation of HIV-1 transmission clusters and drug-resistant mutations in Denmark, 2004 to 2016
por: Petersen, Andreas, et al.
Publicado: (2018)

Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis
por: Cegielski, Peter, et al.
Publicado: (2012)

Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development
por: Bax, Dorine A., et al.
Publicado: (2009)

Unlocking the Molecular Secrets of Antifolate Drug Resistance: A Multi-Omics Investigation of the NCI-60 Cell Line Panel
por: Rushing, Blake R.
Publicado: (2023)

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
por: Kashif, M., et al.
Publicado: (2015)

Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
por: Sorensen, M., et al.
Publicado: (1995)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

An attempt at biochemical characterisation of histologically well defined tumours.
por: Sheth, N. A., et al.
Publicado: (1966)

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs
por: Decazes, Pierre, et al.
Publicado: (2023)

Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
por: Haley, James, et al.
Publicado: (2016)

The diagnostic accuracy of the GenoType® Mtbdrsl assay for the detection of resistance to second-line anti-tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2014)

Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding
por: Scott, Nathan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lhareu076sdv2dt3sl3gvvpffj